aspect
of
surgeon)
→
ReceivesAction
→
randomized
Typicality: | 0.432 |
Saliency: | 0.426 |
between doublet chemotherapy | 5 | other |
between bevacizumab | 5 | other |
to undergo an appendectomy | 5 | purpose |
patient → be → randomized | 21 |
patient → be → randomised | 9 |
negative | neutral | positive |
0.144 | 0.812 | 0.045 |
Raw frequency | 30 |
Normalized frequency | 0.426 |
Modifier score | 0.500 |
Perplexity | 50.036 |